Innovative Medicines Initiative 2 (IMI 2)

Innovative Medicines Initiative 2 is one of five Public-Private Partnerships (PPP), called “Joint Technology Initiatives”, under Horizon 2020.

The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. Building on the results of its predecessor, IMI, IMI 2 is a public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The goal of the programme is to develop next generation vaccines, medicines and treatments, such as new antibiotics. In particular, IMI 2 aims to deliver:

  • a 30% better success rate in clinical trials of priority medicines identified by the WHO;
  • clinical proof of concept in immunological, respiratory, neurological and neurodegenerative diseases in just five years;
  • new and approved diagnostic markers for four of these diseases and at least two new medicines which could either be new antibiotics or new therapies for Alzheimer’s disease.

Like its predecessor, IMI 2 will unite companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.

IMI 2 will provide Europeans with more efficient and effective medicines and treatments, including the increasing numbers of older individuals. Cost savings will ease the burden on public healthcare systems and greater coordination across industry sectors will result in more reliable and faster clinical trials, and better regulation. IMI 2 research and innovation efforts will also open new commercial possibilities based on new services and products. The research, industry and societal sectors involved in IMI2 will benefit from the cooperation and knowledge sharing which take place in these projects.

Budget & Duration

IMI 2 will run for 10 years starting in 2014. The total budget is €3.3 billion, with €1.6 billion coming from Horizon 2020 and €1.6 billion in in kind contributions from EFPIA.

More details are available on the IMI website.